Learn More
CD267 Rat anti-Human, Brilliant Violet 421, Clone: 1A1-K21-M22 (also known as 1A1), BD Optibuild™
Description
The 1A1-K21-M22 monoclonal antibody specifically binds to CD267 which is also known as TACI (Transmembrane Activator and CAML Interactor). CD267 is a member of the of the Tumor Necrosis Factor Receptor (TNFR) Superfamily and is encoded by the TNFRSF13B gene. This 32 kDa type III transmembrane protein receptor binds to the ligands, BAFF (TNFSF13B/BLyS/CD257) and APRIL (TNFSF13/CD256). Ligand-bound CD267 transduces signals leading to the activation of transcription factors including NFAT, AP1, and NF-kappa-B. CD267 is expressed most notably on maturing subsets of B cells and myeloma cells. In CD267 deficient mice, B cell numbers are increased and mice develop autoimmune disorders suggesting that CD267 plays an important role in the regulation of B cell homeostasis.
Specifications
Specifications
| Antigen | CD267 |
| Classification | Monoclonal |
| Clone | 1A1-K21-M22 (also known as 1A1) |
| Concentration | 0.2mg/mL |
| Conjugate | Brilliant Violet 421 |
| Formulation | Aqueous buffered solution containing ≤0.09% sodium azide. |
| Gene Alias | TACI, TNFRSF13B, Tumor necrosis factor receptor 13B, TNFRSF14B2, CVID2 |
| Host Species | Rat |
| Immunogen | Human TACI-transfected RBL cells |
| Purification Method | Affinity Purified |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.